96417 Chemotherapy intravenous infusion each additional seq
Also known as: sequential chemo infusion, additional sequential chemotherapy
Chemotherapy anti-neoplastic agent administration by intravenous infusion, each additional sequential infusion.
In Plain Language
additional sequential cancer medicine
Clinical Context
Each additional sequential intravenous chemotherapy infusion when multiple different agents are administered in sequence.
RVU Breakdown
| Work RVU | 0.21 |
| Total RVU | 0.21 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
With a work RVU of 0.21, this code ranks in the 13th percentile among Medicine codes — 3.7x below the median (0.78). The highest wRVU in this category is 23.92.
Specialties
Frequently Asked Questions
What is CPT code 96417?
CPT 96417 (Chemotherapy intravenous infusion each additional seq) is a Medicine code. Chemotherapy anti-neoplastic agent administration by intravenous infusion, each additional sequential infusion.
Who uses CPT code 96417?
CPT 96417 is used by Oncology, Hematology. Each additional sequential intravenous chemotherapy infusion when multiple different agents are administered in sequence.
When is CPT 96417 used?
Each additional sequential intravenous chemotherapy infusion when multiple different agents are administered in sequence.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.